Basics Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $925.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.72 | 3.57% Avg Daily Range (30 D): $0.28 | 2.67% Avg Daily Range (90 D): $0.40 | 3.17% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 1,584 Avg Inst. Trade: $2.03M Avg Inst. Trade (30 D): $1.24M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.88M Avg Closing Trade (30 D): $1.2M Avg Closing Trade (90 D): $1.58M Avg Closing Volume: 104.99K     News Jun 6, 2025 @ 11:00 AM Nurix Therapeutics to Host a Webcast Conference Ca... Source: N/A Jun 2, 2025 @ 12:12 PM Sanofi Expands Rare Immunology Portfolio With Blue... Source: Vandana Singh Apr 28, 2025 @ 8:00 PM Nurix Therapeutics Presents Data at the AACR 2025 ... Source: N/A Apr 8, 2025 @ 8:00 PM Nurix Therapeutics Reports First Quarter 2025 Fina... Source: Nurix Therapeutics, Inc. Mar 14, 2025 @ 8:00 PM Nurix Therapeutics Reports Inducement Grants Under... Source: Globe Newswire Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.67 $-.67 Diluted EPS $-.67 $-.67 Revenue $ $ 18.45M $ 12.59M Gross Profit $ $ $ Net Income / Loss $ $ -56.35M $ -48.96M Operating Income / Loss $ $ -62.86M $ -54.61M Cost of Revenue $ $ $ Net Cash Flow $ $ -34.08M $ -17.75M PE Ratio